Atropine-Induced Anticholinergic Syndrome Following Off-Label Sublingual Administration for Refractory Sialorrhea: A Case Report. [PDF]
CureusReboredo P +4 more
europepmc +1 more source
Marked Improvement of Sialorrhea with Safinamide in Parkinson's Disease: A Case Series. [PDF]
Mov DisordOnder H, Comoglu S.
europepmc +1 more source
Management of Paediatric Sialorrhea: Outcomes of Botulinum Toxin and Surgical Procedures in a UK Tertiary Centre. [PDF]
Clin OtolaryngolYapp J +4 more
europepmc +1 more source
Ultra-Rapid Cycling Bipolar Disorder: A Case Report. [PDF]
CureusKaplan SK, Zafar J, Lovejoy K.
europepmc +1 more source
Acceptability of Atropine Eyedrops Administered Sublingually for Sialorrhea Treatment Related to Neurological Conditions. [PDF]
Pharmacol Res PerspectMichelon H +6 more
europepmc +1 more source
Clinical and autonomic correlates of chronic Sialorrhea in Parkinson's disease: a questionnaire-based study with cluster analysis of autonomic and dysphagia burden. [PDF]
Clin Park Relat DisordOkusa S +4 more
europepmc +1 more source
Atropine for the treatment of paediatric sialorrhea: a retrospective case series. [PDF]
Paediatr Child HealthSloof N +3 more
europepmc +1 more source
Association Between Clinical Dysphagia Assessment Tools and Videofluoroscopic Findings in Amyotrophic Lateral Sclerosis: A Retrospective Study. [PDF]
Medicina (Kaunas)Manay B +5 more
europepmc +1 more source
Efficacy of transdermal scopolamine for sialorrhea in patients with amyotrophic lateral sclerosis
application/pdfBackground: Sialorrhea, the excessive flow of saliva from the mouth, causes distress in about half of patients with amyotrophic lateral sclerosis (ALS). Treatments of sialorrhea in ALS include systemic anticholinergic drugs, amitriptyline,
Odachi, Kiyomi +2 more
core
The Stomatognathic System as an Expanding Frontier for Botulinum Toxin Therapy. [PDF]
Toxins (Basel)Yoshida K.
europepmc +1 more source